ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,250,000 | -62.3% | 539,028 | -71.9% | 0.00% | -50.0% |
| Q3 2017 | $8,612,000 | +4.0% | 1,918,197 | +6.3% | 0.00% | 0.0% |
| Q2 2017 | $8,280,000 | +13.4% | 1,803,902 | +4.0% | 0.00% | 0.0% |
| Q1 2017 | $7,303,000 | +5.9% | 1,734,482 | +3.8% | 0.00% | 0.0% |
| Q4 2016 | $6,899,000 | -51.2% | 1,670,433 | -4.3% | 0.00% | -50.0% |
| Q3 2016 | $14,145,000 | +2.0% | 1,746,227 | -1.8% | 0.00% | 0.0% |
| Q2 2016 | $13,871,000 | -18.2% | 1,778,333 | -19.1% | 0.00% | 0.0% |
| Q1 2016 | $16,962,000 | -51.3% | 2,197,161 | -32.0% | 0.00% | -55.6% |
| Q4 2015 | $34,848,000 | -53.6% | 3,229,711 | -70.3% | 0.01% | -57.1% |
| Q3 2015 | $75,160,000 | -12.1% | 10,876,836 | +12.7% | 0.02% | -4.5% |
| Q2 2015 | $85,498,000 | -14.4% | 9,649,917 | -4.8% | 0.02% | -15.4% |
| Q1 2015 | $99,934,000 | +257.3% | 10,135,370 | +343.9% | 0.03% | +271.4% |
| Q4 2014 | $27,969,000 | +1251.8% | 2,283,192 | +1001.4% | 0.01% | +600.0% |
| Q3 2014 | $2,069,000 | +99.1% | 207,300 | +51.0% | 0.00% | – |
| Q2 2014 | $1,039,000 | +392.4% | 137,300 | +114.5% | 0.00% | – |
| Q1 2014 | $211,000 | -89.6% | 64,000 | -89.5% | 0.00% | -100.0% |
| Q4 2013 | $2,030,000 | -13.5% | 611,500 | -21.3% | 0.00% | 0.0% |
| Q3 2013 | $2,347,000 | -77.3% | 777,000 | -38.5% | 0.00% | -66.7% |
| Q2 2013 | $10,339,000 | – | 1,263,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |